Your session is about to expire
← Back to Search
Platelet Rich Plasma
Efficacy and Safety of Platelet Rich Plasma in Androgenetic Alopecia
N/A
Waitlist Available
Led By Jerry Shapiro, MD
Research Sponsored by Vancouver General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if injecting platelet-rich plasma (PRP) into the scalp can help people with androgenetic alopecia (a common type of hair loss) regrow hair. PRP is made from a person's own blood and contains high levels of natural growth factors. The goal is to see if these growth factors can stimulate hair growth without the side effects of current treatments. PRP has shown promising results in previous studies for treating androgenetic alopecia by stimulating hair growth through its high levels of natural growth factors.
Eligible Conditions
- Male Pattern Baldness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PRP/SalineExperimental Treatment1 Intervention
Same patient will be injected with PRP and normal saline. Each one will be inject on half head.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PRP
2014
Completed Phase 4
~1860
Find a Location
Who is running the clinical trial?
Vancouver General HospitalLead Sponsor
41 Previous Clinical Trials
19,655 Total Patients Enrolled
Jerry Shapiro, MDPrincipal InvestigatorProfessor
2 Previous Clinical Trials
120 Total Patients Enrolled